NHGRI Director Eric Green, M.D., Ph.D., reflects on the lasting legacy of the Human Genome Project 25 years after its start. Among HGP's far-reaching impacts: team science, data sharing and analysis, and technology development.
An international team of scientists from the 1000 Genomes Project Consortium has created the world's largest catalog of genomic differences among humans, providing researchers powerful clues to why some people are susceptible to various diseases. Understanding how these differences - called genomic variants - contribute to disease may help clinicians de […]
Infertility - difficulty getting or staying pregnant - can come at a high financial and emotional cost, affecting about 6 million women and 4 million men in the United States. Half of these cases could be due to genetic factors. Now, new research techniques are yielding insight into the genetics of infertility. The August Genome Advance of the Month looks at […]
The National Science Foundation (NSF) and the U.S. Commerce Department's National Institute of Standards and Technology (NIST) announced today the University of Michigan at Ann Arbor will lead a consortium to identify new, emerging areas of advanced manufacturing that would benefit from shared public-private investment in research and development, educa […]
The National Science Foundation (NSF) has provided more than $6.5 million in awards for research exploring ways to expand and ease access to manufacturing services. In 30 projects involving 28 universities, faculty and students will research, prototype and test new Web-based manufacturing operating systems and apps to run on them. Their new designs will ensu […]
Watching clouds go by, swirls of white puff up and melt away. The changes mirror mixing within the clouds as drier air mingles with water-saturated air. New research led by scientists at Michigan Technological University, along with the National Center for Atmospheric Research (NCAR) and Mainz University, analyzes this mixing with holographic imaging and an […]
TEV-48125, a monoclonal anti-calcitonin-gene related peptide antibody, is well tolerated and effective in the prevention of high-frequency episodic migraine and chronic migraine, findings from two phase IIb studies show.